#Onchocerciasis Market Demand | Explore Tumblr posts and blogs

vikibro1 · 12 hours ago

Text

Onchocerciasis Market Demand, Opportunities and Forecast By 2029

The Onchocerciasis Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2029. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Brief Overview of the Onchocerciasis Market:

The global Onchocerciasis Market is expected to experience substantial growth between 2024 and 2031. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-onchocerciasis-market

Which are the top companies operating in the Onchocerciasis Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Onchocerciasis Market report provides the information of the Top Companies in Onchocerciasis Market in the market their business strategy, financial situation etc.

Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Allergan,Inc (Ireland), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Abbott (U.S.), bioMérieux (France), BD (U.S.), Danaher (U.S.), Thermo Fisher Scientific Inc., (U.S.), Siemens (Germany), Agilent Technologies, Inc, (U.S.), Merck KGaA (Germany), Fluidigm (U.S.). QIAGEN (Germany), Bio-Rad Laboratories, Inc. (U.S.), Cytiva (U.S.), Stryker (U.S.)

Report Scope and Market Segmentation

Which are the driving factors of the Onchocerciasis Market?

The driving factors of the Onchocerciasis Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Onchocerciasis Market - Competitive and Segmentation Analysis:

**Segments**

- **Type**: The market can be segmented into two main types, namely, River Blindness and Skin Diseases. - **Treatment**: Treatment segments include Medication and Surgery. - **Distribution Channel**: The market can be further divided based on the distribution channel, such as Hospitals, Clinics, Retail Pharmacies, and Online Pharmacies.

**Market Players**

- **Merck & Co., Inc.**: Merck & Co., known as MSD outside the United States and Canada, is a global healthcare leader working to address health challenges. - **Pfizer Inc.**: Pfizer is an American multinational pharmaceutical corporation. - **Johnson & Johnson Services, Inc.**: Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. - **GlaxoSmithKline plc**: GlaxoSmithKline is a British pharmaceutical company headquartered in Brentford, London. - **Novartis AG**: Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.

The global onchocerciasis market is poised for significant growth by 2029, driven by factors such as increasing awareness about neglected tropical diseases, rising healthcare expenditure, and growing government initiatives for disease eradication programs in endemic regions. River Blindness and Skin Diseases are the major segments based on the type of onchocerciasis, with treatment options including medication and surgery. Distribution channels such as hospitals, clinics, retail pharmacies, and online pharmacies play a crucial role in reaching out to patients in need of treatment.

Key market players such as Merck & Co., Inc., Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, and Novartis AG are actively involved in research and development activities, strategic collaborations, and product launches to strengthen their market presence and address the unmet needs of patients suffering from onchocerciasis. These companies are focusingThe global onchocerciasis market is expected to witness substantial growth in the coming years, primarily driven by an increase in awareness about neglected tropical diseases and the rising healthcare expenditure across regions. Onchocerciasis, also known as river blindness, is a parasitic disease caused by the filarial worm Onchocerca volvulus, transmitted through the bites of infected blackflies. It primarily affects the skin and eyes, leading to severe itching, skin depigmentation, and visual impairment, including blindness if left untreated. Skin diseases caused by onchocerciasis can have significant social and economic impacts on affected individuals and communities.

The treatment segments for onchocerciasis include medication and surgery. Medications such as ivermectin and doxycycline are commonly used to kill the parasites responsible for the disease and alleviate symptoms. In some cases, surgery may be necessary to remove nodules or address complications such as skin lesions or visual impairment. The choice of treatment depends on the severity of the disease and individual patient factors.

The distribution channels for onchocerciasis treatment play a crucial role in ensuring access to care for affected individuals. Hospitals and clinics provide specialized medical services and expertise for the diagnosis and management of onchocerciasis. Retail pharmacies play a key role in dispensing medications prescribed by healthcare providers, while online pharmacies offer convenience and accessibility for patients seeking treatment options remotely. The availability of treatment through diverse distribution channels helps expand the reach of healthcare services and improve patient outcomes.

Key market players such as Merck & Co., Inc., Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, and Novartis AG are actively involved in research and development efforts to advance the treatment options for onchocerciasis. These companies leverage their scientific expertise, technological capabilities, and global networks to discover and develop innovative therapies for neglected tropical diseases. Strategic collaborations with academic institutions, government agencies, and**Market Players**

- **Merck & Co., Inc.** - **Pfizer Inc.** - **Johnson & Johnson Services, Inc.** - **GlaxoSmithKline plc** - **Novartis AG** - **Pfizer Inc (U.S.)** - **AstraZeneca (U.K.)** - **Bristol-Myers Squibb Company (U.S.)** - **Allergan,Inc (Ireland)** - **Dr. Reddy's Laboratories Ltd (India)** - **Endo International plc (Ireland)** - **Teva Pharmaceutical Industries Ltd (Israel)** - **Sun Pharmaceutical Industries Ltd (India)** - **Mylan N.V. (U.S.)** - **Novartis AG (Switzerland)** - **Abbott (U.S.)** - **bioMérieux (France)** - **BD (U.S.)** - **Danaher (U.S.)** - **Thermo Fisher Scientific Inc. (U.S.)** - **Siemens (Germany)** - **Agilent Technologies, Inc, (U.S.)** - **Merck KGaA (Germany)** - **Fluidigm (U.S.)** - **QIAGEN (Germany)** - **Bio-Rad Laboratories, Inc. (U.S.)** - **Cytiva (U.S.)** - **Stryker (U.S

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Onchocerciasis Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global Onchocerciasis Market, expected to exhibit impressive growth in CAGR from 2024 to 2029.

Explore Further Details about This Research Onchocerciasis Market Report https://www.databridgemarketresearch.com/reports/global-onchocerciasis-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.

Neutral perspective on the Onchocerciasis Market scenario

Recent industry growth and new developments

Competitive landscape and strategies of key companies

The Historical, current, and estimated Onchocerciasis Market size in terms of value and size

In-depth, comprehensive analysis and forecasting of the Onchocerciasis Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the Onchocerciasis Market report are U.S., Canada and Mexico in North America, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA

Detailed TOC of Onchocerciasis Market Insights and Forecast to 2029

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Onchocerciasis Market Landscape

Part 05: Pipeline Analysis

Part 06: Onchocerciasis Market Sizing

Part 07: Five Forces Analysis

Part 08: Onchocerciasis Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Onchocerciasis Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Japan: https://www.databridgemarketresearch.com/jp/reports/global-onchocerciasis-market

China: https://www.databridgemarketresearch.com/zh/reports/global-onchocerciasis-market

Arabic: https://www.databridgemarketresearch.com/ar/reports/global-onchocerciasis-market

Portuguese: https://www.databridgemarketresearch.com/pt/reports/global-onchocerciasis-market

German: https://www.databridgemarketresearch.com/de/reports/global-onchocerciasis-market

French: https://www.databridgemarketresearch.com/fr/reports/global-onchocerciasis-market

Spanish: https://www.databridgemarketresearch.com/es/reports/global-onchocerciasis-market

Korean: https://www.databridgemarketresearch.com/ko/reports/global-onchocerciasis-market

Russian: https://www.databridgemarketresearch.com/ru/reports/global-onchocerciasis-market

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 1340

Email:- [email protected]

#Onchocerciasis Market Size #Onchocerciasis Market Shares #Onchocerciasis Market Forecast #Onchocerciasis Market Growth #Onchocerciasis Market Demand

0 notes

market-insider · 4 years ago

Text

Fundus Cameras Market Size Worth $625.1 Million By 2024

The global fundus cameras market size is expected to reach a value of USD 625.1 million by 2024, based on a new report by Grand View Research, Inc. Rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.

For instance, according to the WHO 2016 report, globally, there were about 422 million diabetic patients (8.5% of total population) in 2014, as compared to 108 million in 1980. Furthermore, it also states that there is a decline in blindness caused by infections such as trachoma and onchocerciasis, and an increasing trend of non-communicable causes of blindness such as Age-related Macular Degeneration (AMD), glaucoma, and Diabetic Retinopathy (DR). Availability of advanced fundus devices such as portable and hybrid cameras at affordable rates is expected to boost the fundus camera industry during the forecast period.

For PDF sample Copy or More Details please visit link @: https://www.grandviewresearch.com/industry-analysis/fundus-cameras-market

In addition, supportive government regulations for medical devices are anticipated to drive the market over the coming years. For instance, regulatory agencies in the U.S. and Japan require the fundus imaging cameras to be replaced once in every 4 years. Hence, the demand of fundus cameras is consistent in these regions.

Full Press Release @: https://trendinresearchreport.wordpress.com/2020/09/17/fundus-cameras-market-size-forecasts/

#Fundus Cameras Market Size

0 notes

affiliatetejas · 4 years ago

Text

Ophthalmic Femtosecond Lasers Market Forecast 2026

To Gain More Insights into the Ophthalmic Femtosecond Lasers Market, Browse Summary of the Research Report –

Femtosecond laser are ultrafast and ultrashort lasers that release optical pulses 10-15/seconds. The generation of short pulses are achieved by using the passive mode locking technique. This technique is used for generating pulses of light in very short duration (such as for picosecond or femtosecond durations). The femtosecond lasers are popular among ophthalmologists, as such devices help in simplifying and avoiding complex processes of open surgeries. Flap creation in laser in situ keratomileusis (LASIK) is the most common use of this type of laser. It can also be used for other corneal refractive procedures, cataract surgery, and lamellar and full thickness corneal transplantation. The femtosecond laser allows thin and uniform flaps that improve the stability, safety, and precision of the flaps. Added advantage of the femtosecond laser is that it allows the medical doctor to select the cutting angle, position, and diameter of the hinge, as well as the flap diameter and flap thickness, which may offer better flap stability and reduce clinical epithelial ingrowth.

https://www.coherentmarketinsights.com/ongoing-insight/ophthalmic-femtosecond-lasers-market-385

According to Centre for Disease Control and Prevention (CDC), cataract is the prominent blinding condition in the 116 countries enclosed by the Blindness Data Bank in the World Health Organization (WHO) Program for the Prevention of Blindness, nearly 42 million people were affected by severe loss of vision, with cataract being the main cause in 17 million of these cases in 2014. Cataract was the prime cause of blindness in 43.6% of country reports in the same year.

According to Centre for Disease Control and Prevention in 2015, approximately 20.5 million people in the U.S. suffered from cataract, mainly those aged 40 years and older. One of the foremost drivers for ophthalmic femtosecond lasers market is an increasing incidence rate of cataract and rising geriatric population. Among emerging economies, cataract is the major cause of severe visual impairment. World Health Organization carried out a population-based prevalence survey for blindness, across various regions in Africa that are not endemic for trachoma or onchocerciasis, and discovered a blindness rate of around 1%, with cataract accounting for 40%-50% of visual loss cases.

“We Do Offer Sample of Ophthalmic Femtosecond Lasers Market Report. Kindly go through the follow information in order to access sample copy.”

https://www.coherentmarketinsights.com/insight/request-sample/385

Refractive error can include near-sightedness (myopia), astigmatism or presbyopia, farsightedness (hyperopia). There are several surgical actions for correcting or adjusting eye's focusing ability by reshaping the cornea, or clear, round dome at the front of your eye.

Table of Contents

https://www.coherentmarketinsights.com/ongoing-insight/toc/385

Top players in the market

Key players operating in the global ophthalmic femtosecond lasers market are IMRA America, Inc., Newport Corporation, Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec, and Ziemer Ophthalmic Systems.

Research methodology adopted by Coherent Market Insights

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Request A Sample Copy Ophthalmic Femtosecond Lasers Market Report Click here:

https://www.coherentmarketinsights.com/insight/request-sample/385

Get PDF Research Report Brochure @

https://www.coherentmarketinsights.com/insight/request-pdf/385

Buy Now this Premium Report to Grow your Business @

https://www.coherentmarketinsights.com/insight/buy-now/385

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

Name: Mr. Raj Shah

Email: [email protected]

Phone: US +12067016702

Country: United States

Visit our Blog: https://hospitalhealthcareblog.wordpress.com/

0 notes

coolluminaryland-blog1 · 6 years ago

Text

Onchocerciasis Treatment Market : Key Drivers & On-going Trends 2017 - 2025

Global Onchocerciasis Treatment Market: Snapshot

Commonly known as river blindness, onchocerciasis is caused by infection due to a parasitic worm that can lead to serious complications. The parasitic worm, Onchocerca volvulus, is generally imparted within the human skin though bites received from a particular black fly from the Simulium family. Several bites are usually required for the infection to initiate inside the human body, but can cause problems once it does. The worms, once they enter the body, start producing larvae that can travel back towards the skin and infect another black fly that bites the infected human.

Read Report Overview: https://www.transparencymarketresearch.com/onchocerciasis-treatment-market.html

The core diagnostics for onchocerciasis include the use of a biopsy on the skin with regular saline. The medical personnel then wait for the larva to come out. Another procedure involves searching for the larvae in the eye as well as sensing bumps under the skin which is a sign of adult worms. There is currently no vaccine against river blindness and most of the efforts against the disease are directed towards the regular treatment of the likely patient base every year. Ivermectin is the drug used to treat patients every six months to one year, while doxycycline reduces the worms’ strength to antibiotics.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22727

The solution incapacitates and executes microfilariae, diminishing exceptional itching skin and ending the movement towards visual impairment. It additionally keeps grown-up worms from delivering more microfilariae for a couple of months taking after treatment, in this way lessening transmission. The commonness of disease can fluctuate amongst towns and was verifiably as high as 80 to 100 percent by the age of 20 years in a few territories, with visual impairment topping at 40 to 50 years old. Preceding control exercises, hyper endemic areas were as often as possible terminated in view of high rates of visual impairment.

Onchocerciasis Treatment Market: Drivers and Restraints

Onchocerciasis treatment market has influenced the demand in recent years, soaring market capitalization of smaller players, rising number of strategic partnerships to scoop out the best of emerging medications or drugs, increased R&D spending by big pharma and emerging players, expanded indications for approved drugs and rising competition between companies producing drugs for same indications are majorly driving the overall onchocerciasis market. A current review in Mali and Senegal has given the primary confirmation of disposal following 15-17 years of treatment. Taking after this finding, the African Program for Onchocerciasis Control (APOC) has begun a precise assessment of the long haul effect of ivermectin treatment ventures and the attainability of end in APOC upheld nations.

Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=22727

The World Health Organization has focused on Onchocerciasis for worldwide disposal in select nations in Africa by 2020. Control and disposal programs for this irresistible sicknesses by utilizing the medication ivermectin to stop transmission. Together with evidence of-idea for onchocerciasis disposal with yearly CDTI (community directed treatment with ivermectin) from foci in Senegal and Mali, this has brought about focusing on onchocerciasis end in chose African nations by 2020 and in 80% of African nations by 2025. The difficulties for meeting these objectives incorporate the quantity of endemic nations where struggle has deferred or intruded on control programs, cross-fringe foci, and possible growth of organism strains with low helplessness to ivermectin and co-endemicity of loiasis, another parasitic vector borne malady, which backs off or denies CDTI execution. Some of these difficulties could be tended to with new medications or medication mixes with a higher impact on Onchocerca Volvulus than ivermectin. Troublesome manufacturing procedures of this medication is in charge of its high value, which confines its utilization. There are risks of severe side effects. Uncertainty by the government regulations, also low guidance from doctors in selecting proper drug, reimbursement coverage may be weak sometimes and accuracy or medical technology infancy is concern to a certain extent during the forecast period. While the orphan Onchocerciasis treatment market is for the most part limited to the U.S. what’s more, Africa now, pharmaceutical organizations are probably going to begin taking advantage of the African market — which has a high populace of untreated uncommon sicknesses in 2017–2018. In addition, the emergence of effective generic drugs for the treatment of onchocerciasis is expected to encourage the growth of the market during the forecast period. The growing focus of governments in emerging countries on the development of healthcare infrastructure and creating an awareness regarding the condition are additional positive factors assessed to quicken the development of the onchocerciasis treatment market.

Segmentation by Drugs

Segmentation By End User

Storomectol (oral)

Ivermectin (oral)

Hospitals

Specialty Clinics

Others

It is to be expected that the global market of orphan onchocerciasis treatment will show steady growth. Pharmaceutical and medical industries have gained popularity by generating new drugs for treatment of Onchocerciasis. Advancement in this field has been moved by different motivating forces, for example, quick track survey conventions, more medical campaigns, government funding and R&D expenses provided by authorized specialists in selective countries, majorly in Africa. Some of the major key players for orphan Onchocerciasis treatment market are Merck & Co., Inc., Mayne Pharma Group, Par Pharmaceutical Companies, Inc., Delta Pharma Ltd., Life Pharmaceutical Company and Taj Pharmaceuticals Limited.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com/

0 notes

globalrketresearchanalysis · 7 years ago

Text

Boosting Demand Of Neglected Tropical Disease Diagnosis Market Due To Emerging Trend Of Point-Of-Care Testing (POCT) Services Till 2025

The global neglected tropical diseases diagnosis market size is expected to reach USD 7.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 4.1% CAGR during the forecast period. The combined effect of high impact factors such as soaring disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Rising concern regarding Neglected Tropical Diseases (NTD) and its global impact on population as well as governments has fueled demand for development of early disease detection methods. This growth in concern is evident by launch of a substantial number of programs aiming to combat NTDs.

For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

Browse full research report on Neglected Tropical Disease Diagnosis Market: www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market

Further key findings from the report suggest:

By disease type, dengue captured the largest share over other NTDs in 2016. Growing dengue cases and development of novel products for its diagnosis is expected to help this segment maintain its dominance in the coming years

Conventional diagnostic methods accounted for the majority share owing to high market penetration of these techniques, including pathogen culturing, biochemical methods, gram staining, and serology tests

Molecular/modern diagnostic methods are growing at a lucrative pace and are expected to supplant conventional techniques in the coming years. This is majorly due to the advantages of molecular tests with respect to accuracy, specificity, and timelines

Centralized services held the largest share in 2016 owing to easy access to these services; however, point-of-care testing (POCT) services are anticipated exhibit lucrative growth in the coming years owing to benefits such as portability and ease of use

By end use, home healthcare is expected to be the fastest growing segment as a result of growing popularity and demand for POCT services

Asia Pacific is estimated to be the largest regional market and is expected to maintain its position throughout the forecast period thanks to constant growth in GDP, presence of a large target population, and high prevalence of neglected tropical diseases in the region

Abbott; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; and Omega Diagnostics Group PLC are some of the key players operating in this market.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global neglected tropical diseases diagnosis market on the basis of disease, diagnostic method, end use, service type, and region:

Neglected Tropical Diseases Diagnosis Disease Outlook (Revenue, USD Million, 2014–2025)

Dengue

Chikungunya

Rabies

Leprosy

Buruli Ulcer

Yaws

Lymphatic Filariasis

Taeniasis/Cysticercosis

Foodborne Trematodiases

Echinococcosis

Chagas Disease (American Trypanosomiasis)

Dracunculiasis

African Trypanosomiasis

Soil-transmitted Helminth Infections

Onchocerciasis

Schistosomiasis

Scabies and Other Ectoparasites

Snakebite Envenoming

Leishmaniasis

Neglected Tropical Diseases Diagnosis Diagnostic Method Outlook (Revenue, USD Million, 2014–2025)

Conventional Method

Molecular/Modern Method

Neglected Tropical Diseases Diagnosis Service Type Outlook (Revenue, USD Million, 2014–2025)

Centralized Service

POC Service

Neglected Tropical Diseases Diagnosis End-use Outlook (Revenue, USD Million, 2014–2025)

Clinical Labs

Hospitals /Clinics

Home Healthcare

Neglected Tropical Diseases Diagnosis Regional Outlook (Revenue, USD Million, 2014–2025)

Asia Pacific

India

China

Indonesia

Malaysia

Latin America

Brazil

Venezuela

Colombia

Middle East & Africa

Nigeria

North America

U.S.

Canada

Europe

Germany

U.K.

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-neglected-tropical-diseases-diagnosis-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

#Neglected Tropical Disease Diagnosis Market #Neglected Tropical Disease Diagnosis Market Size #Neglected Tropical Disease Diagnosis Market Analysis #Neglected Tropical Disease Diagnosis Market Trends #Neglected Tropical Disease Diagnosis Market Research

0 notes

elizabethmock1248-blog · 7 years ago

Text

Onchocerciasis Treatment Market Growth, Share, Demand and Analysis of Key Players to 2025

Request Brochure of the Report @ www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22727

Onchocerciasis is likewise alluded to as waterway visual impairment and contaminates more than 37 million people who are living close quick moving streams and additionally waterways of sub-Saharan range of Africa. Few cases likewise have been accounted for out of Yemen and the Americas. Onchocerciasis is accepted to be the fourth driving reason for preventable visual impairment. Roughly 500,000 of people tainted with onchocerciasis are outwardly genuinely debilitated and another around 270,000 have turned out to be visually impaired for all time from this sickness. An extensive variety of causes lie behind these infections, yet for large portions of them the cause is obscure. There is no present specific treatment, and specialists must attempt to diminish the infection purely. Oral drugs has been as of late appeared to moderate the movement of sickness in a few patients. It is the world’s second driving irresistible reason for visual impairment. WHO prescribes treating onchocerciasis with ivermectin at any rate once yearly for around 10-15 years. The solution incapacitates and executes microfilariae, diminishing exceptional itching skin and ending the movement towards visual impairment. It additionally keeps grown-up worms from delivering more microfilariae for a couple of months taking after treatment, in this way lessening transmission. The commonness of disease can fluctuate amongst towns and was verifiably as high as 80 to 100 percent by the age of 20 years in a few territories, with visual impairment topping at 40 to 50 years old. Preceding control exercises, hyper endemic areas were as often as possible terminated in view of high rates of visual impairment.

Request Pre Book @ www.transparencymarketresearch.com/checkout.php?rep_id=22727&ltype=S

Onchocerciasis Treatment Market: Drivers and Restraints

Report Details @ www.transparencymarketresearch.com/onchocerciasis-treatment-market.html

0 notes

healthy-insights · 7 years ago

Text

Orphan Lung Diseases Treatment Market Key Trends and Opportunity Analysis 2025

Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are endemic to regions mainly in Africa, Asia and the Americas. These scatters influence 1 billion individuals worldwide and can bring about distortion, long lasting disabilities and dreariness, and in the long run prompt the demise of 1 million individuals every year. Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Illustrations incorporate essential ciliary dyskinesia, numerous cystic lung diseases and idiopathic eosinophilic pneumonias. Patients can along these lines feel "stranded" in the realm of human services.

Influenced individuals may experience issues in finding a specialist experienced in this sickness, and the conclusion is regularly much of the time deferred. Numerous uncommon infections are orphans, but some orphan diseases are not uncommon (e.g. some parasitic infections in immature nations). Few orphan lung diseases: namely, Lymphangioleiomyomatosis, Systemic sclerosis (scleroderma), Idiopathic chronic eosinophilic pneumonia (or ICEP), Pulmonary alveolar proteinosis (PAP) and Idiopathic pulmonary fibrosis (often called IPF). An extensive variety of causes lie behind these infections, yet for large portions of them the cause is obscure.

Some of these conditions are hereditary. This implies they can be passed from guardians to kids, in spite of the fact that they may happen haphazardly as a result of gene damage (mutation). There is no present specific treatment, and specialists must attempt to diminish side effects, for example by giving oxygen. Therapeutic treatment has been as of late appeared to moderate the movement of sickness in a few patients. Women with cutting edge phases of the disease may require a lung transplant. Specifically, there are medications to treat pulmonary arterial hypertension. A few patients with pulmonary fibrosis are additionally given medications to make their immune system less dynamic.

Request a sample of this report -

https://www.persistencemarketresearch.com/samples/15133

Orphan Lung Diseases Treatment Market: Drivers and Restraints

Orphan lung diseases treatment market has influenced the demand, rising market capitalization of pharmaceutical players, increasing number of partnerships and acquisitions to expose the best emerging therapies or medications, improved R&D, expanded indications for approved orphan drugs and growing struggle between companies manufacturing orphan drugs for similar indications are few important co-factors driving the overall orphan lung diseases market. As per U.S. govt., the extent of new FDA-approved drugs that were submitted as orphan medications has rised with a peak of 41% last year (2016). Orphan medications are not only lifelines for patients experiencing these incapacitating illnesses, additionally a gigantic development open door for the pharma business. With return on investments about twice that of non-orphan drugs, R&D movement for more current orphan drug development is relied upon to witness an exponential increment sooner rather than later. Most enormous pharma players are gaining by uncommon ailment medications by improving their pipelines or by securing promising particles of littler organizations.

There are risks of severe side effects. Government regulations, also selection of proper drug by doctors, reimbursement coverage and improper reach of medical technology in rural regions is a major concern to a certain extent which can hamper the growth of orphan lung diseases during the forecast period.

Now, pharmaceutical organizations are probably going to begin taking advantage of the Asian market — which has a high populace of untreated uncommon diseases. The more typical orphan illnesses are exemplified by the alleged ignored irresistible sicknesses, which are endemic to regions assaulted by neediness in Africa, Asia and the Americas. These scatters influence 1 billion individuals worldwide and can bring about distortion and inevitably prompt the passing of 1 million individuals yearly. The ignored tropical irresistible diseases contain lymphatic filariasis, African trypanosomiasis, schistosomiasis, trachoma, onchocerciasis, leishmaniasis, Chagas infection, and many more. Conjunction with AIDS or intestinal diseases is normal. Access to medications is restricted by monetary cost. However, a few pharmaceutical organizations have given medications to treat dismissed tropical issue (e.g .albendazole for lymphatic filariasis).

It is to be expected that the global market of orphan lung disease treatment will show steady growth. Pharmaceutical and medical industries have gained huge profit by generating new drugs for treatment of orphan lung diseases. High number of new product and therapies are entering the market which impose can impose the growth globally. Advancement in this field has been moved by different motivating forces, for example, quick track survey conventions, diminished improvement timetables, tax reductions by the legislature on R&D expenses and livens, for example, showcase selectiveness and open doors for label expansions provided by authorized specialists. An astounding 49 orphan drugs were approved by the FDA in 2014.

Request a ToC of this report -

https://www.persistencemarketresearch.com/toc/15133

Some of the major key players for orphan lung disease treatment market are GSK, Pfizer, Celgene, Novartis, NPS Pharmaceuticals, Auspex Pharmaceuticals, Synageva BioPharma, Roche Pharmaceuticals and Sanofi.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: [email protected]

Web: http://www.persistencemarketresearch.com

0 notes

marketresearchinsight-blog · 8 years ago

Text

Fundus Camera Market is segmented on the basis of Product, End-Use, and Region 2024

The Global Fundus Camera Market is expected to reach a value of USD 625.1 million by 2024, based on a new report by Grand View Research, Inc. Rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.

Access for full Detail of Report@ http://www.grandviewresearch.com/industry-analysis/fundus-cameras-market

Further Key Findings From the Study Suggest:

Non-mydriatic fundus cameras segment dominated the market in 2015 due to an increased demand, as it enables the practitioner to view the retinal anatomy in detail and provides enhanced diagnosis and management of eye diseases.

Non-mydriatic and mydriatic camera can be further sub-segmented into tabletop and handheld cameras. Tabletop cameras segment dominated in 2015 because of the availability of a higher number of commercialized products and ability to produce a better image quality than handheld products.

By end use, ophthalmic & optometrist offices accounted for the largest share of the market in 2015 due to the availability of well-equipped offices in North America and Europe, and preference of patients for primary eye care.

North America dominated the market in 2015 and is expected to maintain its position during the forecast period, due to the local presence of major players and increased awareness about eye disorders.

Asia Pacific is anticipated to be the fastest growing segment during the forecast period due to rising healthcare expenditure and increasing cases of retinal detachment, DR, and AMD.

Some of the players operating in this industry are Carl Zeiss Meditec, Inc.; Kowa Company, Ltd.; NIDEK Co., Ltd., Topcon Medical Systems, Inc.; Canon, Inc.; Clarity Medical Systems, Inc.; Optomed Oy (Ltd.); and Optovue, Inc.

View all Related Reports from same Category: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the fundus camera market by product, end-use, and region:

Fundus camera market Product Outlook (Revenue in USD Million, 2013 - 2024)

Mydriatic Fundus Cameras

Non-mydriatic Fundus Cameras

Tabletop

Handheld

Hybrid Fundus Cameras

ROP Fundus Cameras

Tabletop

Handheld

Fundus camera market End Use Outlook (Revenue in USD Million, 2013 - 2024)

Hospitals

Ophthalmology Clinics

Ophthalmic & Optometrist Offices

Fundus camera market Regional Outlook (Revenue in USD Million, 2013 - 2024)

North America

U.S.

Canada

Europe

Germany

Asia Pacific

Japan

China

Latin America

Brazil

Mexico

Middle East and Africa

South Africa

Browse Press Release of this Report

@ http://www.grandviewresearch.com/press-release/global-fundus-cameras-market

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

For more Information visit us@ www.grandviewresearch.com

0 notes

marketresearchinsightsrepor-blog · 8 years ago

Text

Fundus Camera Market is expected to reach a value of USD 625.1 million by 2024

The global fundus camera market is expected to reach a value of USD 625.1 million by 2024, based on a new report by Grand View Research, Inc. Rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.

To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/fundus-cameras-market

Further key findings from the study suggest:

North America dominated the market in 2015 and is expected to maintain its position during the forecast period, due to the local presence of major players and increased awareness about eye disorders.

Asia Pacific is anticipated to be the fastest growing segment during the forecast period due to rising healthcare expenditure and increasing cases of retinal detachment, DR, and AMD.

See More Reports of This Category: http://www.grandviewresearch.com/industry/medical-devices

About Grand View Research:

Contact:

Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: www.grandviewresearch.com

#Fundus Camera Market #Healthcare

0 notes

coolluminaryland-blog1 · 6 years ago

Text

Onchocerciasis Treatment Market Expected to Witness a Sustainable Growth by 2025

Global Onchocerciasis Treatment Market: Snapshot

Read Report Overview: https://www.transparencymarketresearch.com/onchocerciasis-treatment-market.html

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22727

Onchocerciasis Treatment Market: Drivers and Restraints

Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=22727

Segmentation by Drugs

Segmentation By End User

Storomectol (oral)

Ivermectin (oral)

Hospitals

Specialty Clinics

Others

About us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com/

0 notes

globalrketresearchanalysis · 8 years ago

Text

Fundus Camera Market Reach $625.1 Million By 2024: Grand View Research, Inc.

Browse full research report on Fundus Camera Market:http://www.grandviewresearch.com/industry-analysis/fundus-cameras-market

Further Key Findings From the Study Suggest:

North America dominated the market in 2015 and is expected to maintain its position during the forecast period, due to the local presence of major players and increased awareness about eye disorders.

Asia Pacific is anticipated to be the fastest growing segment during the forecast period due to rising healthcare expenditure and increasing cases of retinal detachment, DR, and AMD.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the fundus camera market by product, end-use, and region:

Fundus camera market Product Outlook (Revenue in USD Million, 2013 - 2024)

Tabletop

Handheld

Tabletop

Handheld

Fundus camera market End Use Outlook (Revenue in USD Million, 2013 - 2024)

Hospitals

Ophthalmology Clinics

Ophthalmic & Optometrist Offices

Fundus camera market Regional Outlook (Revenue in USD Million, 2013 - 2024)

U.S.

Canada

Germany

Japan

China

Brazil

Mexico

South Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-fundus-cameras-market

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

For more Info: www.grandviewresearch.com

#Fundus Camera Market #Fundus Camera Market Size #Fundus Camera Market Analysis #Fundus Camera Market Trends

0 notes